Harnessing the Untapped Potential of Nucleotide‐binding Oligomerization Domain Ligands for Cancer Immunotherapy
Medicinal Research Reviews - United States
doi 10.1002/med.21557
Full Text
Open PDFAbstract
Available in full text
Date
December 13, 2018
Authors
Publisher
Wiley